| scholarly article | Q13442814 |
| P50 | author | Masaya Yamamoto | Q72998352 |
| Zarana Patel | Q73495586 | ||
| Yasuhiko Tabata | Q88802574 | ||
| P2093 | author name string | Antonios G Mikos | |
| Hiroki Ueda | |||
| P2860 | cites work | rhBMP-2 release from injectable poly(DL-lactic-co-glycolic acid)/calcium-phosphate cement composites. | Q51835327 |
| Ectopic bone formation via rhBMP-2 delivery from porous bioabsorbable polymer scaffolds | Q56956579 | ||
| The biology of bone graft repair | Q70245182 | ||
| Repairing of rabbit skull defect by dehydrothermally crosslinked collagen sponges incorporating transforming growth factor beta1 | Q72998356 | ||
| Engineering bone regeneration with bioabsorbable scaffolds with novel microarchitecture | Q77336764 | ||
| Expression of bone morphogenetic proteins in fracture healing | Q77902221 | ||
| rhBMP-collagen sponges as osteoinductive devices: effects of in vitro sponge characteristics and protein pI on in vivo rhBMP pharmacokinetics | Q78026871 | ||
| In vivo degradation of porous poly(propylene fumarate)/poly(DL-lactic-co-glycolic acid) composite scaffolds | Q81422485 | ||
| Collagen sponges for bone regeneration with rhBMP-2 | Q28185098 | ||
| Soft and hard tissue response to photocrosslinked poly(propylene fumarate) scaffolds in a rabbit model | Q30790887 | ||
| Effect of bioresorbable fibres (Polyfibre) and a bioresorbable foam (Polyfoam) on new bone formation. A short term experimental study on the rabbit skull | Q33199368 | ||
| Matrix metalloproteinases in repair | Q33815962 | ||
| Protein release from gelatin matrices | Q33933231 | ||
| Potential applications and delivery strategies for bone morphogenetic proteins | Q34019865 | ||
| Gelatin as a delivery vehicle for the controlled release of bioactive molecules | Q34464776 | ||
| Fracture healing as a post-natal developmental process: molecular, spatial, and temporal aspects of its regulation. | Q35077692 | ||
| Alternative acrylic bone cement formulations for cemented arthroplasties: present status, key issues, and future prospects | Q36858133 | ||
| BMP-silk composite matrices heal critically sized femoral defects | Q37226424 | ||
| Effect of a freeze-dried CMC/PLGA microsphere matrix of rhBMP-2 on bone healing | Q37360883 | ||
| Current understanding of osteoconduction in bone regeneration | Q38547805 | ||
| Development of biocompatible synthetic extracellular matrices for tissue engineering | Q38551581 | ||
| Bone morphogenetic protein encapsulated with a biodegradable and biocompatible polymer | Q38561006 | ||
| THE PREPARATION OF I-131-LABELLED HUMAN GROWTH HORMONE OF HIGH SPECIFIC RADIOACTIVITY | Q39512876 | ||
| Dual growth factor delivery from degradable oligo(poly(ethylene glycol) fumarate) hydrogel scaffolds for cartilage tissue engineering. | Q40461948 | ||
| Distribution and characterization of specific cellular binding proteins for bone morphogenetic protein-2. | Q41360624 | ||
| Recombinant human bone morphogenetic protein-2 binding and incorporation in PLGA microsphere delivery systems | Q41704700 | ||
| The labelling of proteins to high specific radioactivities by conjugation to a 125I-containing acylating agent. Application to the radioimmunoassay | Q42015670 | ||
| Porous bone morphogenetic protein-2 microspheres: polymer binding and in vitro release | Q42563988 | ||
| Controlled release of growth factors based on biodegradation of gelatin hydrogel | Q43595834 | ||
| In vitro release of transforming growth factor-beta 1 from gelatin microparticles encapsulated in biodegradable, injectable oligo(poly(ethylene glycol) fumarate) hydrogels | Q43796482 | ||
| Biodegradation of hydrogel carrier incorporating fibroblast growth factor | Q44007765 | ||
| Mechanical properties of a biodegradable bone regeneration scaffold | Q44123375 | ||
| Crosslinking Characteristics of and Cell Adhesion to an Injectable Poly(Propylene Fumarate-co-Ethylene Glycol) Hydrogel Using a Water-Soluble Crosslinking System | Q44436203 | ||
| Controlled release by biodegradable hydrogels enhances the ectopic bone formation of bone morphogenetic protein | Q44551921 | ||
| Transforming growth factor-beta 1 release from oligo(poly(ethylene glycol) fumarate) hydrogels in conditions that model the cartilage wound healing environment | Q44698554 | ||
| Bioabsorbable scaffolds for guided bone regeneration and generation | Q45757012 | ||
| A biodegradable polymer as a cytokine delivery system for inducing bone formation. | Q45972847 | ||
| Interaction of recombinant human bone morphogenetic protein-2 with poly(d,l lactide-co-glycolide) microspheres | Q46121128 | ||
| In vitro and in vivo release of vascular endothelial growth factor from gelatin microparticles and biodegradable composite scaffolds. | Q46458076 | ||
| Repair of a proximal femoral bone defect in dogs using a porous surfaced prosthesis in combination with recombinant BMP-2 and a synthetic polymer carrier | Q46604418 | ||
| Collagen-hydroxyapatite microspheres as carriers for bone morphogenic protein-4. | Q51305718 | ||
| Effect of varied release kinetics of the osteogenic thrombin peptide TP508 from biodegradable, polymeric scaffolds on bone formation in vivo. | Q51550160 | ||
| P433 | issue | 5 | |
| P921 | main subject | biodegradation | Q696715 |
| morphogenesis | Q815547 | ||
| P304 | page(s) | 1126-1138 | |
| P577 | publication date | 2008-04-22 | |
| P1433 | published in | Acta Biomaterialia | Q4676719 |
| P1476 | title | Biodegradable gelatin microparticles as delivery systems for the controlled release of bone morphogenetic protein-2 | |
| P478 | volume | 4 |
| Q37345739 | 2007 AIChE Alpha Chi Sigma Award: From Material to Tissue: Biomaterial Development, Scaffold Fabrication, and Tissue Engineering |
| Q35589918 | 3D Printing with Nucleic Acid Adhesives |
| Q90182321 | A cancer invasion model of cancer-associated fibroblasts aggregates combined with TGF-β1 release system |
| Q47833156 | A dual-application poly (dl-lactic-co-glycolic) acid (PLGA)-chitosan composite scaffold for potential use in bone tissue engineering. |
| Q57349129 | A glass polyalkenoate cement carrier for bone morphogenetic proteins |
| Q45064228 | A new method for the production of gelatin microparticles for controlled protein release from porous polymeric scaffolds |
| Q28271739 | A review on carrier systems for bone morphogenetic protein-2 |
| Q42563858 | An in situ cross-linking hybrid hydrogel for controlled release of proteins |
| Q91714061 | Angiogenesis in Tissue Engineering: As Nature Intended? |
| Q41831605 | Antibiotic-releasing porous polymethylmethacrylate/gelatin/antibiotic constructs for craniofacial tissue engineering. |
| Q45815488 | Applications and Degradation of Proteins Used as Tissue Engineering Materials. |
| Q90333020 | Auxiliary Biomembranes as a Directional Delivery System To Control Biological Events in Cell-Laden Tissue-Engineering Scaffolds |
| Q46253152 | BMP-2 and bFGF release and in vitro effect on human osteoblasts after adsorption to bone grafts and biomaterials |
| Q55024462 | Bio-Inspired Protein-Based Nanoformulations for Cancer Theranostics. |
| Q46362429 | Biocompatibility and biodegradation of protein microparticle and film scaffolds made from kafirin (sorghum prolamin protein) subcutaneously implanted in rodent models |
| Q38270318 | Biodegradable composite scaffolds incorporating an intramedullary rod and delivering bone morphogenetic protein-2 for stabilization and bone regeneration in segmental long bone defects. |
| Q38682173 | Bioresponsive Injectable Hydrogels for On-demand Drug Release and Tissue Engineering. |
| Q38945314 | Bone Tissue Engineering Challenges in Oral & Maxillofacial Surgery. |
| Q44450910 | Bone morphogenetic protein-2 release from composite hydrogels of oligo(poly(ethylene glycol) fumarate) and gelatin. |
| Q51121664 | Cellular Self-Assembly with Microsphere Incorporation for Growth Factor Delivery Within Engineered Vascular Tissue Rings. |
| Q39289837 | Characterization of recombinant human bone morphogenetic protein-2 delivery from injectable hyaluronan-based hydrogels by means of 125I-radiolabelling |
| Q53071359 | Clinical Application of Bone Morphogenetic Protein-2 Microcarriers Fabricated by the Cryopolymerization of Gelatin Methacrylate for the Treatment of Radial Fracture in Two Dogs. |
| Q44000640 | Controlled release of anti-inflammatory siRNA from biodegradable polymeric microparticles intended for intra-articular delivery to the temporomandibular joint |
| Q38068244 | Controlled release strategies for bone, cartilage, and osteochondral engineering--Part II: challenges on the evolution from single to multiple bioactive factor delivery |
| Q35694277 | Controlled-release and preserved bioactivity of proteins from (self-assembled) core-shell double-walled microspheres |
| Q50559688 | Degradation prediction model and stem cell growth of gelatin-PEG composite hydrogel. |
| Q50847623 | Delivery of a therapeutic protein for bone regeneration from a substrate coated with graphene oxide. |
| Q34600483 | Delivery of plasmid DNA encoding bone morphogenetic protein-2 with a biodegradable branched polycationic polymer in a critical-size rat cranial defect model. |
| Q42240098 | Dose effect of dual delivery of vascular endothelial growth factor and bone morphogenetic protein-2 on bone regeneration in a rat critical-size defect model |
| Q38460704 | Drug delivery from gelatin-based systems |
| Q34457622 | Dual delivery of an angiogenic and an osteogenic growth factor for bone regeneration in a critical size defect model |
| Q57171510 | Effect of scaffold architecture and BMP-2/BMP-7 delivery on in vitro bone regeneration |
| Q92621681 | Efficient in vivo bone formation by BMP-2 engineered human mesenchymal stem cells encapsulated in a projection stereolithographically fabricated hydrogel scaffold |
| Q59019643 | Enhanced Proliferation and Growth of Human Lung Epithelial Cells on Gelatin Microparticle Loaded withEphedraExtracts |
| Q44673173 | Enhanced angiogenic efficacy through controlled and sustained delivery of FGF-2 and G-CSF from fibrin hydrogels containing ionic-albumin microspheres |
| Q28552563 | Evaluation of a Novel HA/ZrO2-Based Porous Bioceramic Artificial Vertebral Body Combined with a rhBMP-2/Chitosan Slow-Release Hydrogel |
| Q34673971 | Evaluation of physical and mechanical properties of porous poly (ethylene glycol)-co-(L-lactic acid) hydrogels during degradation |
| Q33639409 | Formulation, Delivery and Stability of Bone Morphogenetic Proteins for Effective Bone Regeneration. |
| Q35168811 | Founder's award to Antonios G. Mikos, Ph.D., 2011 Society for Biomaterials annual meeting and exposition, Orlando, Florida, April 13-16, 2011: Bones to biomaterials and back again--20 years of taking cues from nature to engineer synthetic polymer sc |
| Q34944475 | Gelatin methacrylate microspheres for controlled growth factor release |
| Q34282125 | Gelatin microspheres crosslinked with genipin for local delivery of growth factors |
| Q92581183 | Gelatin microspheres releasing transforming growth factor drive in vitro chondrogenesis of human periosteum derived cells in micromass culture |
| Q36776620 | Gelatin-methacrylamide gel loaded with microspheres to deliver GDNF in bilayer collagen conduit promoting sciatic nerve growth |
| Q41445497 | Graded porous β-tricalcium phosphate scaffolds enhance bone regeneration in mandible augmentation |
| Q37995448 | Growth factor delivery: how surface interactions modulate release in vitro and in vivo |
| Q47938314 | Growth factor sequestration and enzyme-mediated release from genipin-crosslinked gelatin microspheres. |
| Q50110967 | Harnessing macrophage-mediated degradation of gelatin microspheres for spatiotemporal control of BMP2 release |
| Q49805895 | Highly Efficient Intracellular Protein Delivery by Cationic Polyethyleneimine-Modified Gelatin Nanoparticles. |
| Q38804615 | Hydrolysis and Sulfation Pattern Effects on Release of Bioactive Bone Morphogenetic Protein-2 from Heparin-Based Microparticles |
| Q36539382 | IGF-loaded silicon and zinc doped brushite cement: physico-mechanical characterization and in vivo osteogenesis evaluation |
| Q38116457 | IL-1Ra and its delivery strategies: inserting the association in perspective. |
| Q59111017 | Improved Thrombin Hemostat Using the Cross-Linked Gelatin by Microbial Transglutaminase |
| Q39125971 | Incorporation of growth factor loaded microspheres into polymeric electrospun nanofibers for tissue engineering applications |
| Q57879458 | Incorporation of polymeric microparticles into collagen-hydroxyapatite scaffolds for the delivery of a pro-osteogenic peptide for bone tissue engineering |
| Q41430876 | Influence of the Molecular Weight and Charge of Antibiotics on Their Release Kinetics From Gelatin Nanospheres |
| Q27334661 | Injectable gelatin derivative hydrogels with sustained vascular endothelial growth factor release for induced angiogenesis. |
| Q34457610 | Intra-articular microparticles for drug delivery to the TMJ |
| Q94317452 | Introduction to Editorial Board Member: Professor Antonios (Tony) G. Mikos |
| Q51097656 | Irradiation Sterilized Gelatin-Water-Glycerol Ternary Gel as an Injectable Carrier for Bone Tissue Engineering. |
| Q58861748 | Leads from Physical, Chemical, and Thermal Characterization on Cytotoxic Effects of Xylan-Based Microparticles |
| Q37666179 | Mesenchymal stem cell and gelatin microparticle encapsulation in thermally and chemically gelling injectable hydrogels for tissue engineering. |
| Q33726578 | Modeling of small-molecule release from crosslinked hydrogel microspheres: Effect of crosslinking and enzymatic degradation of hydrogel matrix |
| Q87145257 | Modulation of polyplex release from biodegradable microparticles through poly(ethylenimine) modification and varying loading concentration |
| Q38605185 | Nanotechnology for protein delivery: Overview and perspectives |
| Q57172152 | Natural-Based and Stimuli-Responsive Polymers for Tissue Engineering and Regenerative Medicine |
| Q54660147 | Novel bioresorbable strontium hydroxyapatite membrane for guided bone regeneration. |
| Q36867889 | Osteochondral tissue regeneration using a bilayered composite hydrogel with modulating dual growth factor release kinetics in a rabbit model. |
| Q46267137 | Osteogenic potential and synergistic effects of growth factors delivered from a bionic composite system |
| Q37876388 | Polymer-based microparticles in tissue engineering and regenerative medicine |
| Q87194081 | Pre-incubation of chemically crosslinked hyaluronan-based hydrogels, loaded with BMP-2 and hydroxyapatite, and its effect on ectopic bone formation |
| Q39375761 | Preparation and functional evaluation of cell aggregates incorporating gelatin microspheres with different degradabilities |
| Q91911712 | Preparation of EpH4 and 3T3L1 cells aggregates incorporating gelatin hydrogel microspheres for a cell condition improvement |
| Q47950373 | Preparation of cell aggregates incorporating gelatin hydrogel microspheres containing bone morphogenic protein-2 with different degradabilities |
| Q35616430 | Protein and mineral composition of osteogenic extracellular matrix constructs generated with a flow perfusion bioreactor. |
| Q46274373 | Rapid biomineralization of chitosan microparticles to apply in bone regeneration |
| Q37439946 | Release characteristics and osteogenic activity of recombinant human bone morphogenetic protein-2 grafted to novel self-assembled poly(lactide-co-glycolide fumarate) nanoparticles |
| Q26782690 | Research Advances in Tissue Engineering Materials for Sustained Release of Growth Factors |
| Q39403595 | Sequential delivery of BMP-2 and IGF-1 using a chitosan gel with gelatin microspheres enhances early osteoblastic differentiation |
| Q39832845 | Starch-poly-epsilon-caprolactone microparticles reduce the needed amount of BMP-2 |
| Q35981629 | Strategies for controlled delivery of growth factors and cells for bone regeneration |
| Q38261963 | Sustained delivery of biomolecules from gelatin carriers for applications in bone regeneration. |
| Q51543031 | Sustained presentation of BMP-2 enhances osteogenic differentiation of human adipose-derived stem cells in gelatin hydrogels. |
| Q34973974 | Sustained release of BMP-2 in bioprinted alginate for osteogenicity in mice and rats |
| Q38523725 | The application of nanomaterials in controlled drug delivery for bone regeneration |
| Q57217466 | The development of injectable gelatin/silk fibroin microspheres for the dual delivery of curcumin and piperine |
| Q37909452 | The use of micro- and nanospheres as functional components for bone tissue regeneration |
| Q34566292 | Trehalose maintains bioactivity and promotes sustained release of BMP-2 from lyophilized CDHA scaffolds for enhanced osteogenesis in vitro and in vivo |
Search more.